Collegium Pharmaceutical (COLL) Goodwill & Intangibles (2016 - 2026)

Collegium Pharmaceutical's Goodwill & Intangibles history runs 11 years deep, the most recent figure standing at $760.0 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 22.98% year-over-year to $760.0 million; the TTM figure through Mar 2026 stood at $760.0 million (down 22.98% YoY), while the FY2025 annual figure was $815.4 million, down 22.61% from the prior year.
• Goodwill & Intangibles was $760.0 million for Q1 2026 at Collegium Pharmaceutical, down from $815.4 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $1.1 billion in Q1 2022 to a low of $486.5 million in Q2 2024.
• Historically, Goodwill & Intangibles has averaged $881.7 million across 5 years, with a median of $928.4 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles jumped 280.45% in 2022, then tumbled 55.16% in 2024.
• A 5-year view of Goodwill & Intangibles shows it stood at $701.2 million in 2022, then declined by 20.77% to $555.6 million in 2023, then soared by 89.67% to $1.1 billion in 2024, then retreated by 22.61% to $815.4 million in 2025, then declined by 6.8% to $760.0 million in 2026.
• The last three Goodwill & Intangibles figures came in at $760.0 million (Q1 2026), $815.4 million (Q4 2025), and $870.9 million (Q3 2025), per Business Quant data.